GRN163L
Showing 26 - 50 of 4,630
Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)
Not yet recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaYuan Kong
Sep 4, 2023
Novel Subtypes of Polycystic Ovary Syndrome
Recruiting
- Polycystic Ovary Syndrome
- Long-term follow-up
-
Hershey, Pennsylvania
- +10 more
Nov 4, 2023
Evaluation of Membrane Lung Function in High-altitude Regions
Not yet recruiting
- Extracorporeal Membrane Oxygenation
- +2 more
- Monitoring membrane lung function at different altitudes
-
Beijing, Beijing, ChinaBeijing Chao-Yang Hospital
Nov 22, 2023
Post-ERCP Acute Pancreatitis, NSAIDs, Indomethacin Trial in China (100mg diclofenac, 100mg indomethacin)
Recruiting
- Post-ERCP Acute Pancreatitis
- +4 more
- 100mg diclofenac
- 100mg indomethacin
-
Chongqing, Chongqing, China
- +10 more
Jul 7, 2023
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)
Not yet recruiting
- Pancreatic Cancer
- Gemcitabine
- +2 more
-
Baltimore, MarylandSKCCC Johns Hopkins
Aug 16, 2023
Chordoma, Chemo Effect Trial in Beijing (camrelizumab and apatinib)
Recruiting
- Chordoma
- Chemotherapy Effect
- camrelizumab and apatinib
-
Beijing, Beijing, ChinaBEIJING
Nov 14, 2023
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)
Not yet recruiting
- Myelofibrosis
- TQ05105 Tablets
- TQB3617 Capsules
-
Guangzhou, Guangdong, China
- +19 more
Nov 7, 2023
Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)
Recruiting
- Hematological Malignancy
- Cancer-Related Anemia
- Shengxuening Tablet
- Ferrous succinate
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Mar 13, 2023
Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)
Recruiting
- Thyroid Cancer
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 13, 2023
LCI in Chronic Atrophic Gastritis and Early Gastric Cancer
Recruiting
- CAG - Chronic Atrophic Gastritis
- EGC - Early Gastric Cancer
- Compare color information and mucosal microvascular density
-
Beijing, Beijing, ChinaThe Fifth Medical Center of Chinese PLA General Hosptial
Nov 21, 2023
Platelets-rich Plasma, Osteoarthritis Knees Both, Meniscus Disorder Trial in Xi'an (Sodium hyaluronate injection)
Recruiting
- Platelets-rich Plasma
- +3 more
- Sodium hyaluronate injection
-
Xi'an, Shannxi, ChinaXijing Hospital
Oct 9, 2023
Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
- Best-Available Therapy(BAT) Regimen
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Oct 10, 2023
Venous Thromboembolism Trial in Beijing
Recruiting
- Venous Thromboembolism
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences Fuwai Hospital
Oct 5, 2023
Acute Respiratory Failure, Acute Respiratory Distress Syndrome Trial in China (Transbronchial lung cryobiopsy, Transbronchial
Recruiting
- Acute Respiratory Failure
- Acute Respiratory Distress Syndrome
- Transbronchial lung cryobiopsy
- Transbronchial lung biopsy
-
Beijing, China
- +5 more
Mar 3, 2023
Tryptophan Metabolites in Pediatric Migraine
Recruiting
- Migraine in Children
- tryptophan metabolites in plasma
-
Jinan, ChinaJunhui Liu
Jul 23, 2023
Blood Metabolic Markers in Type 2 Diabetes Mellitus of Different
Not yet recruiting
- Diabetes Mellitus, Type 2
- No intervention
-
Jinan, Shandong, ChinaPeng Wu
Nov 24, 2023
Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)
Recruiting
- Extensive-stage Small Cell Lung Cancer
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 27, 2023
Immunotherapy in Advanced or Locally Advanced dMMR/MSI-H
Recruiting
- Colorectal Cancer
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 18, 2023
Triple-Negative Breast Cancer Trial in China (JS001, Nab-Paclitaxel, Placebo)
Recruiting
- Triple-Negative Breast Cancer
- JS001
- +2 more
-
Beijing, Beijing, China
- +55 more
Sep 13, 2022
Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))
Recruiting
- Severe Aplastic Anemia
- Anti-Thymocyte Globulin (Rabbit)
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Sep 9, 2023
Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)
Recruiting
- Diabetic Peripheral Neuropathic Pain
- HSK16149 20mg BID
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Nov 2, 2023
Acute Ischemic Stroke, Basilar Artery Occlusion, Thrombosis Trial in China (Endovascular treatment, Intravenous thrombolysis
Not yet recruiting
- Acute Ischemic Stroke
- +4 more
- Endovascular treatment
- Intravenous thrombolysis (Alteplase)
-
Hefei, Anhui, China
- +44 more
Nov 29, 2022